Technology
CircleDNA is powered by the most advanced Next Generation Sequencing (NGS) technology, for accurate results you can trust.
Your DNA, your (full) health story
Next Generation Sequencing (NGS) is an advanced DNA analytic technology utilized by esteemed medical institutions and cutting-edge research centers, such as the UK’s NHS, Harvard University, and Stanford University. It’s a state-of-the-art tool that allows rapid sequencing of vast amounts of DNA information.
Imagine that every gene is like a book. Traditional genotyping technology analyzes your genes by looking at the equivalent of only a few sentences, knowing what you are looking for – however, you remain unaware of the unknown narrative. With targeted Next Generation Sequencing (NGS) technology, we are capable of generating reports that summarize a more comprehensive volume of your health – not just a few sentences.
Why read just a sentence when you can read the whole book?
Traditional Genotyping TechnologyAs an example, recreational tests only look at a few variants of the BRCA 1/2 gene, which creates a high likelihood of producing a false-positive result. | Next Generation Sequencing TechnologyMeanwhile, CircleDNA looks at the whole “book” for the BRCA 1/2 gene, covering 5,791 known variants that affect your risk of breast and ovarian cancer. | |
Number of genetic data points | Hundreds of thousands | > 3 million |
Sampling data volume | Dozens of MB | > 100 MB |
Device | Microarray scanner | Novaseq (Next Generation Sequencing) |
Ability to detect new mutations? | No | Yes |
Powered by the world’s most advanced DNA technology
CircleDNA's NGS technology conducts a targeted gene sequencing, providing you with comprehensive and accurate results
Our laboratory
All samples submitted to CircleDNA are processed in our own internationally accredited laboratory with NGS technology.
We utilise NovaSeqTM 6000 systems, manufactured in the USA, by Illumina — the global market leader in DNA sequencing equipment.
99.9%
International Accreditation
Developed by global leaders in DNA sequencing
Prof. Michael M Yang, PhD
VP (Research and Technology), Prenetics Yeung Kin-Man Chair Professor of Biomedical Sciences, City University of Hong Kong
Prof. Stephen Tsui, PhD
Head of Division of Genomics and Bioinformatics, The Chinese University of Hong Kong
Dr. Lawrence Tzang, PhD
Chief Scientific Officer & Co-founder, Prenetics Founding Member, Hong Kong Society for Behavioural and Neural Genetics
Dr. Senthil Sundaram, MD
Chief Clinical Officer, Prenetics Genetic Researcher, National Institute of Health
Our global awards
